Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

CRH Medical Corp (CRH.TO)

CRH Medical Corp (CRH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

CRH Medical Corp 999 Canada Place Suite 578, World Trade Center Vancouver BC V6C 3E1 CAN

https://www.crhsystem.com P: 425-658-0151 F: 604-633-1443

Description:

CRH Medical Corp is a healthcare products and services company. The company, through its subsidiaries, provides anesthesiology services to gastroenterologists in the United States. It also specializes in the treatment of hemorrhoids utilizing its treatment protocol and patented proprietary technology. The company's product, the CRH O'Regan System, is a single-use, disposable, hemorrhoid treatment. It distributes the CRH O'Regan System, treatment protocols, operational and marketing services directly to gastroenterologists. Geographically, the company operates in the United States and Canada, of which key revenue is derived from the United States.

Key Statistics

Overview:

Market Capitalization, $K 357,386
Shares Outstanding, K 71,620
Annual Sales, $ 106,172 K
Annual Net Income, $ -24,476 K
Last Quarter Sales, $ 36,783 K
Last Quarter Net Income, $ -19,152 K
60-Month Beta 3.22
% of Institutional Shareholders 13.34%

Growth:

1-Year Return 76.33%
3-Year Return 37.85%
5-Year Return 22.91%
5-Year Revenue Growth 18.18%

Per-Share Information:

Latest Earnings Date 05/11/21
Earnings Per Share ttm -0.34
EPS Growth vs. Prev Year -772.55%
Most Recent Dividend 0.140 on 04/29/98
Next Ex-Dividends Date 04/29/98
Dividend Payable Date 01/01/70
Dividend Payout Ratio 0.00%

CRH.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward 200.00
Price/Earnings to Growth N/A
Return-on-Equity % -37.65%
Return-on-Assets % -12.40%
Profit Margin % -23.05%
Debt/Equity 1.33
Price/Sales 2.69
Price/Book 5.32
Book Value/Share 0.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar